Motusol Max (Diclofenac Diethylamine)

Diclofenac diethylamine topical gel acts locally on inflammatory pathways to alleviate pain in various musculoskeletal conditions.

• Musculoskeletal pain: provides local analgesic and anti‑inflammatory effects to reduce discomfort.
• Sprains and strains: diminishes swelling and eases movement limitation at the injury site.
• Osteoarthritis: alleviates joint pain and stiffness by targeting inflammatory mediators.
• Inflammatory skin conditions: reduces localized inflammation and erythema when applied to affected areas.

• Diclofenac diethylamine penetrates the skin and inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in peripheral tissues. By blocking COX activity, it reduces the synthesis of prostaglandins that mediate pain, edema and inflammation. The reversible inhibition is localized, allowing effective anti‑inflammatory action at the application site while limiting systemic exposure. This mechanism underlies its rapid onset of relief when applied to affected areas.

Topical diclofenac may cause local and, rarely, systemic adverse reactions.

Common Side Effects

• Skin irritation: mild redness or itching at the application site.
• Burning sensation: transient warmth or stinging after application.
• Dryness: localized dry skin where the gel is used.
• Pruritus: itching without visible rash.
• Erythema: mild redness of the treated area.
• Rash: superficial skin eruption.

Serious or Rare Side Effects

• Allergic reaction: swelling, hives or anaphylaxis requiring immediate medical attention.
• Stevens‑Johnson syndrome: severe blistering and skin detachment.
• Photosensitivity: exaggerated sunburn response on treated skin.
• Gastrointestinal ulceration: rare systemic effect leading to stomach pain or bleeding.
• Hepatic injury: elevated liver enzymes or hepatitis.
• Renal impairment: reduced kidney function in susceptible individuals.

When using Motusol Max, observe the following precautions to minimize risks and ensure safe application.

• Apply to intact skin: avoid broken skin, open wounds or mucous membranes.
• Limit area and duration: follow label instructions and do not exceed recommended surface area.
• Do not combine with other topical NSAIDs: avoid additive irritation or systemic exposure.
• Review concomitant medications: inform healthcare provider if using oral anticoagulants, systemic NSAIDs or lithium.
• Pregnancy and lactation: discuss potential risks with a physician before use.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Diclofenac diethylamine can interact with systemic drugs; consider the following classifications.

Major Interactions (Avoid)

• Systemic NSAIDs: additive risk of systemic toxicity and gastrointestinal effects.
• Anticoagulants (warfarin, DOACs): increased bleeding tendency.
• Lithium: potential rise in serum lithium concentrations.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor renal function due to possible reduced clearance.
• ACE inhibitors/ARBs: watch for renal impairment when combined with NSAID exposure.